A Phase 1 Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interactions Between RDEA3170 and Febuxostat in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2018
Price : $35 *
At a glance
- Drugs Verinurad (Primary) ; Febuxostat
- Indications Gout
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 30 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Oct 2013 Planned end date changed from 1 Nov 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov record.
- 25 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.